NovaBay Pharmaceuticals (NASDAQ:NBY) will be issuing its quarterly earnings data after the market closes on Wednesday, November 14th. Analysts expect the company to announce earnings of ($0.09) per share for the quarter.
NovaBay Pharmaceuticals stock opened at $1.12 on Friday. NovaBay Pharmaceuticals has a twelve month low of $0.97 and a twelve month high of $4.75.
ILLEGAL ACTIVITY WARNING: This story was first reported by WKRB News and is the property of of WKRB News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.wkrb13.com/2018/11/11/novabay-pharmaceuticals-nby-to-release-earnings-on-wednesday.html.
NovaBay Pharmaceuticals, Inc, a pharmaceutical company, develops, manufactures, and markets anti-infective products for the eye care market in the United States. Its commercial products include the Neutrox family of products, Avenova for the eye care market; Aganocide compounds patented synthetic molecules with a range of spectrum of uses against bacteria, viruses, and fungi; Auriclosene Irrigation Solution for urology; CelleRx for the dermatology market; intelli-Case, a device for soft and rigid gas permeable contact lenses; and NeutroPhase for wound care.
See Also: Fiduciary
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.